Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Rosebank Industries rallies as Citi, Jefferies reinstate coverage at 'buy'

(Sharecast News) - Rosebank Industries rallied on Tuesday after both Citi and Jefferies reinstated coverage of the shares at 'buy'. Jefferies, which has a 470p price target on the stock, said it was reinstating coverage following the completion of the MW & CPM acquisitions.

"Rosebank transitions from a single-asset story to a group of three under-optimised US industrial businesses, and credible improvement levers suggest significant margin upside potential, with early execution at ECI underpinning our confidence in delivery," the bank said.

It added that at 12.7x 27F EV/EBIT, the valuation is supportive and its price target offers 35% potential upside.

Separately, Citi noted that the $2.1bn acquisition of CPM and $950m acquisition of MW Components double the revenue of Rosebank to around $2.4bn when combined with the ECI business acquired last year.

"The model is again to significantly improve margins (by 600-700bps in both cases) and double shareholder investment from the recent £1.9bn equity raise over the planned 3-5 year holding period," it said.

"With the ECI turnaround on track and a strong track record on improving acquired businesses, we see attractive returns and resume coverage with a buy rating and £4.50 target price."

At 1056 BST, the shares were up 3.2% at 356p.

Share this article

Related Sharecast Articles

Berenberg raises target price on Persimmon, keeps 'hold' rating
(Sharecast News) - Analysts at Berenberg raised their target price on housebuilder Persimmon from 1,150p to 1,240p on Friday after lifting their 2026-27 earnings per share estimates by an average of 2% following the group's third-quarter trading update.
Wise H1 profits climb as customer base tops 16m
(Sharecast News) - Global fintech group Wise reported a jump in first-half revenue and profits on Friday, putting the recently dual-listed firm on track to hit the upper end of its full-year growth targets.
GSK wins positive CHMP opinion for Bexsero meningitis B booster
(Sharecast News) - Pharmaceutical giant GSK said on Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use had issued a positive opinion recommending a label update for its Bexsero meningitis B vaccine.
Major Microsoft outage hits hospitals, businesses and financial markets worldwide
(Sharecast News) - A global Microsoft outage has disrupted businesses, government agencies and other organisations worldwide, leaving users without a slew of vital services in what is one of the group's most prolonged service disruptions in history.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.